RLMD peer analysis
Relmada Therapeutics (RLMD) against its competitors: price, today's move, 1-year return and market value side by side.
RLMD and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACET Adicet Bio | $3.10 | -2.21% | -71.93% | – |
| ACRV Acrivon Therapeutics | $1.74 | 4.19% | -19.07% | – |
| CBUS Cibus | $1.24 | 8.77% | -9.49% | – |
| FBIO Fortress Biotech | $1.97 | 1.55% | -20.24% | $64.70M |
| IMUX Immunic | $7.94 | 4.47% | 14.89% | $103.70M |
| LITS Lite Strategy | $1.08 | 3.85% | -38.64% | – |
| PMVP PMV Pharmaceuticals | $1.32 | -3.99% | -1.12% | – |
| TCRX TScan Therapeutics | $0.21 | 11.11% | -83.06% | – |
| RLMD Relmada Therapeutics | $4.17 | -2.34% | 50.54% | $455.48M |
- RLMD's peers: ACET (Adicet Bio), ACRV (Acrivon Therapeutics), CBUS (Cibus), FBIO (Fortress Biotech), IMUX (Immunic), LITS (Lite Strategy), PMVP (PMV Pharmaceuticals), TCRX (TScan Therapeutics).
Updated 2026-11-05 12:48 UTC